IRIDEX (IRIX) Competitors $1.30 +0.04 (+3.17%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$1.24 -0.06 (-5.00%) As of 08/8/2025 04:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IRIX vs. NVNO, NTRB, NSPR, HYPR, VANI, TELA, APYX, LUNG, MDAI, and ICCMShould you be buying IRIDEX stock or one of its competitors? The main competitors of IRIDEX include enVVeno Medical (NVNO), Nutriband (NTRB), InspireMD (NSPR), Hyperfine (HYPR), Vivani Medical (VANI), TELA Bio (TELA), Apyx Medical (APYX), Pulmonx (LUNG), Spectral AI (MDAI), and IceCure Medical (ICCM). These companies are all part of the "medical equipment" industry. IRIDEX vs. Its Competitors enVVeno Medical Nutriband InspireMD Hyperfine Vivani Medical TELA Bio Apyx Medical Pulmonx Spectral AI IceCure Medical enVVeno Medical (NASDAQ:NVNO) and IRIDEX (NASDAQ:IRIX) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends. Is NVNO or IRIX more profitable? enVVeno Medical has a net margin of 0.00% compared to IRIDEX's net margin of -14.61%. enVVeno Medical's return on equity of -57.35% beat IRIDEX's return on equity.Company Net Margins Return on Equity Return on Assets enVVeno MedicalN/A -57.35% -53.49% IRIDEX -14.61%-290.57%-22.86% Do institutionals & insiders believe in NVNO or IRIX? 34.7% of enVVeno Medical shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 16.0% of enVVeno Medical shares are held by insiders. Comparatively, 7.4% of IRIDEX shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has better valuation and earnings, NVNO or IRIX? IRIDEX has higher revenue and earnings than enVVeno Medical. enVVeno Medical is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioenVVeno MedicalN/AN/A-$21.82M-$1.20-3.87IRIDEX$48.67M0.45-$8.91M-$0.43-3.02 Does the media refer more to NVNO or IRIX? In the previous week, enVVeno Medical had 1 more articles in the media than IRIDEX. MarketBeat recorded 1 mentions for enVVeno Medical and 0 mentions for IRIDEX. IRIDEX's average media sentiment score of 0.00 beat enVVeno Medical's score of -0.06 indicating that IRIDEX is being referred to more favorably in the news media. Company Overall Sentiment enVVeno Medical Neutral IRIDEX Neutral Which has more volatility & risk, NVNO or IRIX? enVVeno Medical has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500. Comparatively, IRIDEX has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500. SummaryenVVeno Medical and IRIDEX tied by winning 6 of the 12 factors compared between the two stocks. Get IRIDEX News Delivered to You Automatically Sign up to receive the latest news and ratings for IRIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IRIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRIX vs. The Competition Export to ExcelMetricIRIDEXLASERS IndustryComputer SectorNASDAQ ExchangeMarket Cap$21.83M$975.70M$29.81B$9.71BDividend YieldN/AN/A3.11%4.12%P/E Ratio-3.02N/A50.3924.70Price / Sales0.4559.681,543.56110.27Price / CashN/A25.7533.5728.01Price / Book10.005.547.215.76Net Income-$8.91M-$60.02M$803.97M$267.05M7 Day Performance-1.52%-0.69%0.07%3.13%1 Month Performance28.71%2.23%-0.19%1.27%1 Year Performance-30.11%13.75%24,183.46%22.83% IRIDEX Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRIXIRIDEXN/A$1.30+3.2%N/A-30.1%$21.83M$48.67M-3.02120Upcoming EarningsNVNOenVVeno Medical0.3211 of 5 stars$4.84-0.6%N/A-7.4%$85.40MN/A-4.0330Analyst DowngradeNTRBNutriband3.0023 of 5 stars$7.11-3.8%$13.00+82.8%+31.6%$82.43M$2.14M-7.9010NSPRInspireMD3.4375 of 5 stars$2.67-0.7%$4.50+68.5%-15.4%$82.41M$7.03M-3.5650Positive NewsGap UpHigh Trading VolumeHYPRHyperfine0.7432 of 5 stars$1.18+14.6%$1.06-10.2%+2.7%$80.17M$12.89M-2.19190Upcoming EarningsGap UpVANIVivani Medical2.2316 of 5 stars$1.40+5.3%$4.00+185.7%+16.9%$78.80MN/A-3.2620Upcoming EarningsTELATELA Bio2.9971 of 5 stars$1.85-0.5%$7.25+291.9%-57.6%$73.57M$69.30M-1.31120News CoverageAPYXApyx Medical1.7187 of 5 stars$1.85+5.7%N/A+109.6%$66.14M$48.10M-3.36270Earnings ReportGap UpLUNGPulmonx3.827 of 5 stars$1.65+2.5%$7.66+364.5%-72.3%$64.82M$83.79M-1.15250High Trading VolumeMDAISpectral AI1.9413 of 5 stars$2.42+2.5%$4.75+96.3%+61.6%$59.75M$29.58M-4.4883News CoverageUpcoming EarningsICCMIceCure Medical2.0129 of 5 stars$0.92-8.9%$2.50+171.7%+36.4%$59.28M$3.27M-3.2960Upcoming Earnings Related Companies and Tools Related Companies NVNO Alternatives NTRB Alternatives NSPR Alternatives HYPR Alternatives VANI Alternatives TELA Alternatives APYX Alternatives LUNG Alternatives MDAI Alternatives ICCM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRIX) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IRIDEX Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share IRIDEX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access Sale